Article Text
Abstract
Background: Ankylosing enthesopathy (ANKENT) with progressive stiffening of ankle and tarsal joints of the hind limbs is a naturally occurring arthropathy in B10.BR mice. Some features are similar to those of the spondyloarthropathies in humans.
Objective: To study the role of sexual dimorphism and testosterone in the development of ANKENT.
Methods: The incidence of ANKENT was observed in non-castrated, castrated, and testosterone substituted castrated male mice, and in control and testosterone treated female mice.
Results: ANKENT occurred only in males; it did not develop in males castrated at age 2–3 months but occurred in castrated males injected with testosterone. Females injected with testosterone did not develop ANKENT.
Conclusion: Testosterone can replace what castration eliminates, at least in the postpubertally castrated males, but is itself not sufficient to induce joint disease.
- ANKENT, ankylosing enthesopathy
- AS, ankylosing spondylitis
- MHC, major histocompatibility complex
- SpA, spondyloarthropathies
- spondyloarthropathy
- ankylosing enthesopathy
- ankylosing spondylitis
- testosterone